Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP

NCT05094570 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Nasal Polyps
Staphylococcus Aureus

Interventions

DRUG: Dupilumab Prefilled Syringe

Sponsor

University of Virginia

Collaborators

[object Object]